Hrt Financial LP Axogen, Inc. Transaction History

Hrt Financial LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$3.61 - $7.76 $69,947 - $150,357	19,376 New	19,376 $132,000
Q2 2023 Aug 11, 2023	SELL	$8.5 - $10.38 $92,650 - $113,142	-10,900 Reduced 18.72%	47,337 $432,000
Q1 2023 May 12, 2023	SELL	$7.53 - $10.95 $427,726 - $621,992	-56,803 Reduced 49.38%	58,237 $550,000
Q4 2022 Feb 10, 2023	BUY	$9.44 - $13.09 $935,787 - $1.3 Million	99,130 Added 623.07%	115,040 $1.15 Million
Q3 2022 Nov 14, 2022	BUY	$8.14 - $12.25 $129,507 - $194,897	15,910 New	15,910 $189,000
Q2 2022 Aug 12, 2022	SELL	$6.99 - $10.0 $137,723 - $197,030	-19,703 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.26 - $10.7 $143,043 - $210,822	19,703 New	19,703 $156,000
Q3 2021 Nov 15, 2021	SELL	$15.23 - $21.72 $171,794 - $245,001	-11,280 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$17.8 - $23.5 $200,784 - $265,080	11,280 New	11,280 $243,000
Q4 2020 Feb 16, 2021	SELL	$11.5 - $17.96 $223,560 - $349,142	-19,440 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$10.62 - $13.12 $206,452 - $255,052	19,440 New	19,440 $226,000
Q4 2018 Feb 15, 2019	SELL	$17.09 - $38.25 $216,598 - $484,780	-12,674 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$34.05 - $55.9 $431,549 - $708,476	12,674 New	12,674 $467,000

162

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $661M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.